Affordable Access

Access to the full text

Recent metabolomics and gene editing approaches for synthesis of microbial secondary metabolites for drug discovery and development

Authors
  • Sinha, Rajeshwari1
  • Sharma, Babita2
  • Dangi, Arun Kumar3
  • Shukla, Pratyoosh2
  • 1 Independent Researcher, New Delhi, India , New Delhi (India)
  • 2 Maharshi Dayanand University, Enzyme Technology and Protein Bioinformatics Laboratory, Department of Microbiology, Rohtak, Haryana, 124001, India , Rohtak (India)
  • 3 Independent Researcher, Rohtak, Haryana, India , Rohtak (India)
Type
Published Article
Journal
World Journal of Microbiology and Biotechnology
Publisher
Springer Netherlands
Publication Date
Oct 22, 2019
Volume
35
Issue
11
Identifiers
DOI: 10.1007/s11274-019-2746-2
Source
Springer Nature
Keywords
License
Yellow

Abstract

AbstractMicrobial secondary metabolites (SMs) have been identified as an important natural source of drugs for several metabolic and neurological diseases. Along with biomedical applications, SMs are also used in the food and biochemical industries. SMs include natural products such as pigments, alkaloids, toxins, antimicrobials obtained from cultured microorganisms, while other non-cultivable microorganisms have also acted as a rich source of SMs. But, the isolation of SMs from these sources is a very tedious task. Metabolomics provides complete identification and structural information about the entire cellular metabolome under specific conditions using highly sophisticated instrumentation. Further, gene editing techniques such as cloning and gene refactoring, including advanced CRISPR-Cas, can be used for engineering microbes that have the potential to produce natural SMs that were not produced in native microbial strain. The present review describes integrated metabolomics and gene editing approaches for the synthesis of novel microbial SMs and their potential application towards drug discovery and development.Graphical abstract

Report this publication

Statistics

Seen <100 times